Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 5, 2004, Pages 1265-1268

  Caldwell, Charles G ^a   Chen, Ping ^a   He, Jiafang ^a   Parmee, Emma R ^a   Leiting, Barbara ^a   Marsilio, Frank ^a   Patel, Reshma A ^a   Wu, Joseph K ^a   Eiermann, George J ^a   Petrov, Aleksandr ^a   He, Huaibing ^a   Lyons, Kathryn A ^a   Thornberry, Nancy A ^a   Weber, Ann E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 FLUOROPYRROLIDINE; AMIDE; DIPEPTIDYL PEPTIDASE IV; ENZYME INHIBITOR; GLYCINE DERIVATIVE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SELECTIVITY; DRUG TOLERABILITY; ENZYME INHIBITION; FLUORINATION; INHIBITION KINETICS; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST;

EID: 10744233045     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.12.040     Document Type: Article

References (29)

1. Bailey C.J. Trends in Pharmacol. Sci. 21:2000;259.
2. Moller D.E. Nature. 414:2001;821.
3. Patel M., Rybczynski P.J. Expert Opin. Investig. Drugs. 12:2003;623.
4. Holst J.J. Curr. Med. Chem. 6:1999;1005.
5. Deacon C.F., Holst J.J., Carr R.D. Drugs of Today. 35:1999;159.
6. Livingston J.N., Schoen W.R. Ann. Rep. Med. Chem. 34:1999;189.
7. Zander M., Madsbad S., Madsen J.L., Holst J.J. The Lancet. 359:2002;824.
8. Augustyns A., Van der Veken P., Senten K., Haemers A. Exp. Opin. Ther. Patents. 13:2003;499.
9. Drucker D.J. Exp. Opin. Invest. Drugs. 12:2003;87.
10. Villhauer E.B., Coppola G.M., Hughes T.E. Ann. Rep. Med. Chem. 36:2001;191.
11. Holst J.J., Deacon C.F. Diabetes. 47:1998;1663.
12. Hughes T.E., Mone M.D., Russell M.E., Weldon S.C., Villhauer E.B. Biochemistry. 38:1999;11597.
13. Villhauer E.B., Brinkman J.A., Naderi G.B., Dunning B.E., Mangold B.L., Mone M.D., Russel M.E., Welden S.C., Hughes T.E. J. Med. Chem. 45:2002;2362.
14. Villhauer E.B., Brinkman J.A., Naderi G.B., Burkey B.F., Dunning B.E., Prasad K., Mangold B.L., Russell M.E., Hughes T.E. J. Med. Chem. 46:2003;2774.
15. Schön E., Born I., Demuth H.-U., Faust J., Neubert K., Noll F., Stenmetzer T., Barth A., Ansorge S. Biol. Chem. Hoppe Seyler. 372:1991;305.
16. Pospisilik J.A., Stafford S.G., Demuth H.-U., Brownsey R., Parkhouse W., Finegood D.T., McIntosh C.H.S., Pederson R.A. Diabetes. 51:2002;943.
17. Sorbera L.A., Revel L., Castaner J. Drugs of the Future. 26:2001;859.
18. Ashworth D.M., Atrash B., Baker G.R., Baxter A.J., Jenkins P.D., Jones D.M., Szelke M. Bioorg. Med. Chem. Lett. 6:1996;1163.
19. Parmee, E. R.; He, J.; Mastracchio, A.; Edmondson, S. D.; Colwell, L. E. ; Eiermann, G.; Feeney, W. P.; Habulihaz, B.; He, H.; Kilburn, R.; Leiting, B.; Lyons, K.; Marsilio, F.; Patel, R.; Petrov, A.; di Salvo, J.; Wu, J. K.; Thornberry, N.; Weber, A. E. Bioorg. Med. Chem. Lett., 2004, 14, 43.
20. Augustyns K.J.L., Lambeir A.M., Borloo M., De Meester I., Vedernikova I., Vanhoof G., Hendriks D., Scharpé S., Haemers A. Eur. J. Med. Chem. 32:1997;301.
21. Leiting B., Pryor K.D., Wu J.K., Marsilio F., Patel R.A., Craik C.S., Ellman J.A., Cummings R.T., Thornberry N.A. Biochem. J. 371:2003;525.
22. Rosenblum J.S., Kozarich J.W. Curr. Opin. Chem. Biol. 7:2003;1.
23. Cunningham D.F., O'Connor B. Biochem. Biophys. Acta. 1343:1997;160.
24. Friesen R.W., Ducharme Y., Ball R.G., Blouin M., Boulet L., Cote B., Frenette R., Girard M., Guay D., Huang Z., Jones T.R., Laliberte F., Lynch J.J., Mancini J., Martins E., Masson P., Muise E., Pon D.J., Siegel P.K.S., Styhler A., Tsou N.N., Turner M.J., Young R.N., Girard Y. J. Med. Chem. 46:2003;2413. and references therein.
25. Pearlstein R., Vaz R., Rampe D. J. Med. Chem. 46:2003;2017.
26. Giardina G., Dondio G., Grugni M. Synlett. 1995;55.
27. 3OH)].
28. Kang Y.K., Shin K.J., Yoo K.H., Seo K.J., Park S.Y., Kim D.J., Park S.W. Bioorg. Med. Chem. Lett. 9:1999;2385.
29. Marson C.M., Melling R.C. Chem. Commun. 1998;1223.